Topic: Sanofi-Aventis SA

Sanofi Ends Development Of Insomnia, Clot Drugs

Drugs.com - 768 days ago
Drug developer Sanofi-Aventis said Monday it will stop seeking regulatory approval for a stalled insomnia drug candidate and a prospective heart condition treatment.. Sanofi-Aventis already makes the insomnia treatment Ambien, which recorded third-quarter U.S. sales of about $177.7 million, about the same ...

Ignoring Insomnia Costs America $42 Billion a Year

Drugs.com - 982 days ago
Sanofi-aventis U.S., with research and support from The Center for Medicine in the Public Interest (CMPI), has released a report showing the lag in the diagnosis and treatment of insomnia translates to billions of dollars in lost productivity and absenteeism in the ...

What to watch in 2009

Modern Medicine - 1120 days ago
Keep an eye on key therapeutic areas in 2009, as new drugs go through the FDA pipeline. According to Keith Bradbury, executive director of drug information at Medco Health Solutions Inc., the FDA has delayed approval of many new drug applications (NDAs) ...